Tag: Biotech

EU-Startups

As cancer cases surge toward 35 million by 2050, Finland’s Gosta Labs raises €7.5 million to ease oncology workloads

Gosta Labs, a Helsinki-based HealthTech company innovating in the oncology sector, has closed a €7.5 million Seed round to scale its AI operating system for complex […]
November 27th, 2025
Korea Tech Desk

Venture Week 2025: Korea Prepares “Four-Pillar Strategy” to Become a Global Venture Powerhouse

Korea’s startup scene is about to pause, reflect, and reimagine its future. In the coming first venture week, the nation’s venture and innovation builders, investors, and […]
November 24th, 2025
Korea Tech Desk

Beyond the Scale-Up “Death Valley”: Korea’s Next Test Is Building Global-First Startups, Not Local Giants

Korea’s startup ecosystem has learned to grow fast — perhaps too fast. The past decade’s state-backed acceleration produced record valuations and bold ambitions, but now the […]
November 22nd, 2025
Korea Tech Today

Samsung Revives Dual-CEO Leadership to Navigate AI Era

Executive reshuffle signals strategic focus on mobile, memory, and next-generation technologies Samsung Electronics has reinstated its dual-CEO management structure as part of its 2026 executive reshuffle, […]
November 21st, 2025
EU-Startups

€99 million Series D fuels Artios’ expansion of precision cancer treatment pipeline

Artios Pharma Limited, a British biopharmaceutical company committed to realising the therapeutic potential of targeting the DNA damage response (DDR) in cancer, today announced the successful […]
November 17th, 2025
EU-Startups

With over €4 billion in AUM, France’s Sofinnova closes Fund XI at €650 million to double down on MedTech magic

Paris-based VC firm Sofinnova Partners has closed its latest flagship fund, Sofinnova Capital XI, at an impressive €650 million – a haul that surpasses its original […]
November 17th, 2025
EU-Startups

Cambridge startup T-Therapeutics secures €27.5 million to improve how the immune system targets disease

T-Therapeutics, a British BioTech company developing next-generation T cell receptor (TCR) therapeutics for cancer and autoimmune disease, today announced the successful expansion of its Series A […]
November 13th, 2025
EU-Startups

In bid to improve outcomes for children with genetic bone disease, Swedish startup BOOST Pharma raises additional €3.1 million

Stockholm-based BOOST Pharma, a clinical-stage biopharmaceutical company focused on developing novel cell therapies for rare skeletal pediatric diseases, today announced that Sound Bioventures has joined its […]
November 3rd, 2025
EU-Startups

Dutch startup Source.ag raises €15.2 million to scale AI software powering 300 greenhouses across 18 countries

Source.ag, the Amsterdam-based developer of AI software for Controlled Environment Agriculture (CEA), today announced the successful close of its Series B funding round, raising €15.2 million. […]
November 3rd, 2025
EU-Startups

Spain’s Adaptam Therapeutics secures €3 million to target immune cells that help tumours evade treatment

Adaptam Therapeutics, a San Sebastian-based company pioneering cancer immunotherapies specifically targeting immunosuppressive myeloid cells, today announces the successful completion of a €3 million pre-Seed financing round […]
October 27th, 2025
View more